RG
Ricky Goldwasser Morgan Stanley Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
UnitedHealth
UNH
$286B
| $315.39 | $325 |
3%
upside
| Overweight | 17 days ago |
|
2 |
2
Centene
CNC
$14.2B
| $28.98 | $28 |
3%
downside
| Equal-Weight | 1 month ago |
|
3 |
3
Labcorp
LH
$23.2B
| $278.67 | $306 |
10%
upside
| Overweight | 1 month ago |
|
4 |
4
Doximity
DOCS
$13B
| $69.34 | $60 |
13%
downside
| Equal-Weight | 4 months ago |
|
5 |
5
Charles River Laboratories
CRL
$8.07B
| $163.99 | $184 |
12%
upside
| Equal-Weight | 7 months ago |
|
6 |
6
Lifestance Health
LFST
$2.09B
| $5.37 | $10 |
86%
upside
| Overweight | 1 year ago |
|
7 |
7
GoodRx Holdings
GDRX
$1.39B
| $4 | $5.50 |
38%
upside
| Equal-Weight | 1 year ago |
|
8 |
8
Oscar Health
OSCR
$5.02B
| $19.43 | $7.50 |
61%
downside
| Equal-Weight | 2 years ago |
|
9 |
9
Alignment Healthcare
ALHC
$3.14B
| $15.86 | $12 |
24%
downside
| Overweight | 2 years ago |
|
10 |
10
Quest Diagnostics
DGX
$20.5B
| $183.49 | $145 |
21%
downside
| Equal-Weight | 2 years ago |
|
11 |
11
Molina Healthcare
MOH
$9.47B
| $174.65 | $365 |
109%
upside
| Overweight | 2 years ago |
|
12 |
12
McKesson
MCK
$85.5B
| $687.40 | $420 |
39%
downside
| Overweight | 2 years ago |
|
13 |
13
Humana
HUM
$37B
| $307.92 | $620 |
101%
upside
| Overweight | 2 years ago |
|
14 |
14
Elevance Health
ELV
$70.6B
| $313.64 | $500 |
59%
upside
| Equal-Weight | 2 years ago |
|
15 |
15
CVS Health
CVS
$93.6B
| $73.78 | $124 |
68%
upside
| Overweight | 2 years ago |
|
16 |
16
Cigna
CI
$81.5B
| $305.31 | $318 |
4%
upside
| Overweight | 3 years ago |
|
17 |
17
Cardinal Health
CAH
$35.7B
| $149.56 | $70 |
53%
downside
| Overweight | 3 years ago |
|
18 |
18
IQVIA
IQV
$31.9B
| $187.68 | $195 |
4%
upside
| Overweight | 4 years ago |
|